Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer

J Clin Oncol. 2012 Jun 1;30(16):2019-20; author reply 2020. doi: 10.1200/JCO.2011.41.4581. Epub 2012 Apr 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Cyclooxygenase 2 / analysis*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male

Substances

  • Biomarkers, Tumor
  • Cyclooxygenase 2